Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases that is headquartered in Menlo park, California and was founded in 2014 by Aya Jakobovitis.
On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.
On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.
On January 27, 2016 Adicet Bio acquired the Israeli immunotherapy company Applied Immune Technologies.
Timeline
On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.
On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.